Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
ACS Omega|August 26, 2024
Unveiling the Intricacies of Monoamine Oxidase-A (MAO-A) Inhibition in Colorectal Cancer: Computational Systems Biology, Expression Patterns, and the Anticancer Therapeutic PotentialSanaa K Bardaweel, Husam Al-Salamat, Rima Hajjo, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and NilotinibRima Hajjo, Dima A Sabbah, Raghad Alhaded, et al.
Molecules (Basel, Switzerland)|December 30, 2020
<i>N</i>-Phenyl-6-Chloro-4-Hydroxy-2-Quinolone-3-CarboxAmides: Molecular Docking, Synthesis, and Biological Investigation as Anticancer AgentsDima A Sabbah, Rawan A Haroon, Sanaa K Bardaweel, et al.
Frontiers in Medicine|October 23, 2023
A cross-sectional study confirms temporary post-COVID-19 vaccine menstrual irregularity and the associated physiological changes among vaccinated women in JordanEnsaf Y Almomani, Rima Hajjo, Ahmad Qablan, et al.
Plos One|February 17, 2026
Integrative computational, synthetic, experimental evaluation of targeted inhibitors against matrix metalloproteinase-9: Toward precision modulation of proteolytic activityZainab Ahmed Rashid, Dima A Sabbah, Kamal Sweidan, et al.
International Journal of Molecular Sciences|December 30, 2025
Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular ApproachShriefa Almutairi, Rima Hajjo, Dima A Sabbah, et al.
Journal of Medicinal Chemistry|October 21, 2010
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugsRima Hajjo, Christopher M Grulke, Alexander Golbraikh, et al.
Current Cancer Drug Targets|July 2, 2025
An Overview of the Potential Use of Selective Serotonin Reuptake Inhibitors (SSRIs) in Cancer TreatmentSanaa K Bardaweel, Rima Hajjo, Osama H Abusara, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012-2024)Iyman Alsaad, Diana M A Abdel Rahman, Ola Al-Tamimi, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 18, 2023
New derivatives of sulfonylhydrazone as potential antitumor agents: Design, synthesis and cheminformatics evaluationDima A Sabbah, Bara'a A Al-Azaideh, Wamidh H Talib, et al.
Pageof 5